Skip to main content

Your search for “Therapy Target” returned 457 results

CIRM Funds Six UC San Diego Stem Cell Researchers

September 6, 2012

The governing board of the California Institute for Regenerative Medicine (CIRM) has announced that six investigators from the University of California, San Diego Stem Cell Research program have received a total of more than $7 million in the latest round of CIRM funding. This brings UC San Diego’s total to…

Multiple Brain Regions Moderate and Link Depressive Mood and Pain

May 21, 2019

University of California San Diego School of Medicine research expands and deepens the association between clinical depression and pain, identifying specific regions of the brain that drive, influence and moderate depressive mood and its relationship to perceiving physical pain.

Study: Breast Cancer Drug Shows Potential for Rare Appendix Cancer

October 16, 2024

UC San Diego School of Medicine researchers discover a groundbreaking oral breast cancer drug that is also effective in treating a rare form of appendix cancer.

Targeted Cognitive Training Benefits Patients with Severe Schizophrenia

December 6, 2018

Researchers find that patients with severe, refractory schizophrenia benefit from targeted cognitive therapy, improving auditory and verbal outcomes and the way they process information.

Cognitive Deficits from Meth and PCP Use Are Generated By a Common Neurotransmitter Switch

September 26, 2024

The effects of sustained drug abuse can manifest in many ways. Loss of memory and reduced cognitive functions are some of the effects that can persist for years. Scientists in Neurobiology have now identified a mechanism in the brain that generates drug-induced cognitive impairments.

Inhibiting Enzyme Helps Cancer Immunotherapy Work Better

August 3, 2020

UC San Diego researchers discovered that people with an inactive RNA-editing enzyme respond better to cancer immunotherapy, and inhibitors of the enzyme help mice with difficult-to-treat cancers live longer.

Developmental Protein Plays Role in Spread of Cancer

June 14, 2013

A protein used by embryo cells during early development, and recently found in many different types of cancer, apparently serves as a switch regulating the spread of cancer, known as metastasis, report researchers at the University of California, San Diego School of Medicine and UC San Diego Moores Cancer Center…

Finding Leukemia’s Weakness Using Genome-Wide CRISPR Technology

April 20, 2020

Researchers at University of California San Diego School of Medicine and Moores Cancer Center used CRISPR technology to identify key regulators of aggressive chronic myeloid leukemia.

Genetics Overlap Found Between Alzheimer’s Disease and Cardiovascular Risk Factors

April 16, 2015

An international team of scientists, led by researchers at University of California, San Diego School of Medicine, have found genetic overlap between Alzheimer’s disease (AD) and two significant cardiovascular disease risk factors: high levels of inflammatory C-reactive protein (CRP) and plasma lipids or fats. The findings suggest the two cardiovascular…

Scott M. Lippman, MD, Named New Director of UC San Diego Moores Cancer Center

April 13, 2012

Scott M. Lippman, MD, chair of Thoracic/Head and Neck Medical Oncology at The University of Texas (UT) MD Anderson Cancer Center, has accepted the position of director of Moores Cancer Center at the University of California, San Diego, beginning May 1, 2012.

Category navigation with Social links